[Community acquired pneumonia in children]. 2009

Faten Tinsa, and Khadija Boussetta, and Ahmed Gharbi, and Dorra Bousnina, and Rim Abdelaziz, and Ines Brini, and Souad Bousnina
Service de Médecine Infantile B, Hôpital d'Enfants de Tunis, Tunis, Tunisie.

BACKGROUND Community acquired pneumonia is responsible for a high morbidity in children. The etiological diagnosis is not always easy and treatment remains probabilistic. OBJECTIVE To analysis clinical patterns and the outcome of community acquired pneumonia and to find arguments in favour of its origin. METHODS A prospective analysis of the files of 39 children (20 boys, 19 girls) hospitalized between (1 december 2004 - 30 june 2005) for community acquired pneumonia was performed. Included dchildren whad between 6 months and 15 years-old. RESULTS The mean age was of 3 years and three months. Germ was identified in 41% of cases: Mycoplasma pneumoniae was the most important germ found in 9 cases, pneumococcus was found in 4 cases and hemophilus in four cases. Coinfection pneumococcus and mycoplasma were found in two cases. None virus was identified. We have separated two groups: bacterial pneumonia and pneumoniae without definite etiology. Fat cough was associated to bacterial pneumonia. mycoplama pneumoniae was significantly associated with high fever and dry cough. We haven't found any others associations between clinical, biological or radiological patterns and the two groups of pneumonia. C-reactive protein more than 66 mg/l has sensitivity of 77%, specificity of 73.3%, positive predictive value of 46.7% of and negative predictive value of 91.7%. The outcome was favourable in all cases. CONCLUSIONS Theses results showed the necessity to improve our microbiological methods to identify infectious agents of pneumonia. Mycoplasma pneumonia seems to be a frequent germ in preschool children.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D014416 Tunisia A country in northern Africa between ALGERIA and LIBYA. Its capital is Tunis.
D017714 Community-Acquired Infections Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility. Community Acquired Infection,Community-Acquired Infection,Infections, Community-Acquired,Acquired Infection, Community,Acquired Infections, Community,Community Acquired Infections,Infection, Community Acquired,Infection, Community-Acquired,Infections, Community Acquired

Related Publications

Faten Tinsa, and Khadija Boussetta, and Ahmed Gharbi, and Dorra Bousnina, and Rim Abdelaziz, and Ines Brini, and Souad Bousnina
November 2007, La Revue du praticien,
Faten Tinsa, and Khadija Boussetta, and Ahmed Gharbi, and Dorra Bousnina, and Rim Abdelaziz, and Ines Brini, and Souad Bousnina
December 2003, Paediatrics & child health,
Faten Tinsa, and Khadija Boussetta, and Ahmed Gharbi, and Dorra Bousnina, and Rim Abdelaziz, and Ines Brini, and Souad Bousnina
October 2013, Early human development,
Faten Tinsa, and Khadija Boussetta, and Ahmed Gharbi, and Dorra Bousnina, and Rim Abdelaziz, and Ines Brini, and Souad Bousnina
September 2003, La Revue du praticien,
Faten Tinsa, and Khadija Boussetta, and Ahmed Gharbi, and Dorra Bousnina, and Rim Abdelaziz, and Ines Brini, and Souad Bousnina
January 2018, Recent patents on inflammation & allergy drug discovery,
Faten Tinsa, and Khadija Boussetta, and Ahmed Gharbi, and Dorra Bousnina, and Rim Abdelaziz, and Ines Brini, and Souad Bousnina
May 2005, Current opinion in pulmonary medicine,
Faten Tinsa, and Khadija Boussetta, and Ahmed Gharbi, and Dorra Bousnina, and Rim Abdelaziz, and Ines Brini, and Souad Bousnina
February 2002, The New England journal of medicine,
Faten Tinsa, and Khadija Boussetta, and Ahmed Gharbi, and Dorra Bousnina, and Rim Abdelaziz, and Ines Brini, and Souad Bousnina
December 2023, Pediatric emergency care,
Faten Tinsa, and Khadija Boussetta, and Ahmed Gharbi, and Dorra Bousnina, and Rim Abdelaziz, and Ines Brini, and Souad Bousnina
September 1987, Seminars in respiratory infections,
Faten Tinsa, and Khadija Boussetta, and Ahmed Gharbi, and Dorra Bousnina, and Rim Abdelaziz, and Ines Brini, and Souad Bousnina
December 2023, Pediatric emergency care,
Copied contents to your clipboard!